Walmart earnings affected by GLP-1 inhibitors, HER2 testing in Gyn Cancers mini-video tutorial, SPECTRUM study, Pembrolizumab in clear cell cancers, and a review paper on neuroendocrine tumors
Publications Update # 90
How to give great presentations, censoring in clinical trials causing bias, molecular classification in fertility-sparing treatment of endometrial cancer, ARIEL 4 final OS data, guidelines for using checkpoint inhibitors in older patients
Publications Update # 89
Implications of the Present Perfect Tense, PARP inhibitors and recent withdrawals, retroperitoneal debulking video, ovarian cancer guidelines by ASCO and some GYOEDU updates
Publications Update # 88
Confessions of a recovering people pleaser, deep-dive into the management of non-myoinvasive uterine papillary serous carcinoma
Publications Update # 87
Publications Update # 86
New Year Resolutions, A Practical Approach to Molecular Classification of Endometrial Cancer, Cervical Cancer Review article, management of Cancer Cachexia and the Changing Practice of Gynecology Oncology.
Publications Update # 85
New year resolutions, ENSURE and TOTEM trial with GOG 0258 long-term survival, and modified techniques for laparoscopic radical hysterectomy.
Publications Update # 84
Yo-Yo Ma at the reopening of the Notre Dame, CDK 4/6 inhibitors in endometrial cancer, real-world analysis of folate testing in endometrial cancer, and the inaugural episode of GYOEDU Podcast.
Publications Update # 83
A trick to powerful speaking, LEAP-001 Study: Pembro/Lenvima vs. Carbo/Taxol in EndoCa, Opportunistic Salpingectomy.
Publications Update # 82
Book recommendation - Get It Done by Ayelet Fishbach, MITO-18 trial summary and discussion points, NEJM paper - BALANCE trial, Trial flashback - road to carboplatin and taxol video (5 mins)